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ABSTRACT 
Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis (TB), is 
the leading bacterial cause of death worldwide. A significant barrier to global MTB 
eradication is 'latent' TB infection, where MTB persists in the human host in a 
metabolically dormant and highly drug-tolerant state. Latently infected individuals 
constitute a vast global reservoir of disease (~2 billion people worldwide), and the 
heightened drug tolerance of dormant MTB necessitates long antibiotic treatments (up to 
9 months of combination antibiotic therapy). 
MTB dormancy is thought to be the result of an adaptive response to host-induced 
stresses, involving coordinated transcriptional regulation of hundreds of genes as well as 
numerous metabolic changes. Currently, our understanding of this process is limited by a 
lack of tools for studying dynamic behavior in single cells. Gene regulation is a dynamic 
phenomenon that occurs within each cell individually, but many assays rely on steady-
state measurements of a population average and thus fail to capture important information 
about the dynamics of cellular behavior. Additionally, cell-to-cell phenotypic variation 
Vl 
has been identified as a key source of microbial drug tolerance, further highlighting the 
need for single-cell studies. 
To address this need, we developed a microfluidic platform to study 
Mycobacteria species at the single-cell level. This platform enables on-chip culture and 
fluorescent imaging of live cells in precisely controlled conditions, and can thus be used 
to study dynamic processes within single cells as well as phenotypic heterogeneity across 
a cellular population. We used this platform to obtain diverse new insights about 
mycobacterial biology, using the fast-growing mycobacterium M smegmatis. 1) We 
directly observed gene regulation by the transcription factor KstR in single cells, 
confirming regulatory interactions that had been predicted computationally. 2) We 
analyzed morphology, growth, and division data across hundreds of single cells and 
found that cell division in Mycobacteria is governed using size-based, rather than time-
based, control mechanisms. 3) We found that individual cells exhibit considerable 
differences in their responses to antibiotic stress, and that these differences have 
implications for cellular survival. 
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Antibiotic tolerance: A transient, phenotypic decrease in drug susceptibility. This is 
different than antibiotic resistance, which refers to a genetic mutation. 
Dormancy: A non-replicating or slowly-replicating state ofMTB thought to allow the 
organism to survive in the host for long time periods. 
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CHAPTER ONE: BACKGROUND 
In this Chapter the scientific and public health context of this dissertation work is 
described. Section One focuses on the public health threat posed by M tuberculosis 
(MTB) and in particular, the challenges of treating latent tuberculosis (TB) infections. 
Current scientific opinion regarding MTB dormancy and drug tolerance is summarized, 
including recent insights from the MTB gene regulatory network. Section Two introduces 
recent techniques for acquiring quantitative measurements of single cells in real-time and 
discusses the advantages of single-cell techniques. These advantages include the ability to 
observe heterogeneity within a population of cells, and to measure the dynamics of 
cellular processes. 
Section One: Biology and Public Health Significance of M. Tuberculosis 
Tuberculosis has been known to mankind since antiquity, and yet it confounds 
attempts at global eradication. The reasons for its continued success as a human pathogen 
are multifaceted and still not completely understood. This Section describes the global 
health burden of MTB, with a particular focus on the phenomenon of MTB dormancy 
and drug tolerance, and summarizes current scientific opinion regarding TB pathogenesis. 
Subsection One: Tuberculosis is a Major Global Health Burden 
The pathogenic organism Mycobacterium tuberculosis (MTB) is the causative 
agent of the infectious disease tuberculosis (TB) and is the leading bacterial cause of 
2 
death in humans [1]. Indeed, the scope of the TB epidemic has been called a "global 
health emergency'' [2]. MTB is responsible for three human deaths every 60 seconds, and 
in 2010 there were an estimated 8.8 million new cases ofTB and 1.5 million TB-
associated deaths [3]. The prevalence ofTB in the United States has declined 
dramatically since 1992 [4], to a rate of3.2 cases per 100,000 persons (Figure 1.1). 
However, TB incidence in developing countries and resource-limited areas is often 10 to 
100 times higher than in the United States, with incidence rates in some countries 
reaching >1,000 cases per 100,000 persons [1]. 
Reported TB Cases, United States, 1982-2012 
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Figure 1.1. TB incidence in the United States and worldwide. Adapted from [1] 
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A main cause of MTB' s success as a human pathogen is its ability to reside in the 
human host for years or decades in a dormant state. This dormancy results in a so-called 
'latent' state of infection, i.e., one that does not present discernible external symptoms in 
the infected host [5, 6]. In latent TB infection, the organism persists in a metabolically 
dormant state within alveolar macrophages. [7] Heightened drug tolerance of MTB in the 
dormant state has been identified as a key barrier to eradication ofTB worldwide [8], and 
necessitates long antibiotic treatments (up to 9 months of combination antibiotic therapy) 
[9]. Long antibiotic treatment regimens are expensive and difficult to carry out to 
completion, especially in low-resource settings, and incomplete antibiotic treatment has 
been identified as a major factor in the rise of drug-resistant tuberculosis strains 
(multidrug-resistant tuberculosis, MDR-TB, and extensively drug-resistant tuberculosis, 
XDR-TB) [10]. Latently infected individuals constitute a vast global reservoir ofMTB, 
further hindering efforts at eradication; it is estimated that fully one-third ofthe world's 
population(> 2 billion people) harbor latent TB infection [1]. 
An overview of the process by which MTB infects humans is diagrammed below 
in Figure 1.2, adapted from [ 11]. TB is spread via inhalation of MTB bacilli that are 
released into the air (e.g. via coughing) by an infected person. Infection begins with 
exponential growth of MTB within macrophages; clusters of macrophages then begin to 
aggregate and form a characteristic lesion known as a granuloma [12]. MTB is able to 
evade mechanisms of innate and adaptive immunity [13] using strategies that are not 
fully understood but that include disruption of native host processes such as phagosome 
maturation and macrophage apoptosis [14-16]. 90-95% of infections result in MTB ' s 
dormancy adaptation response and its transition to nonreplicating persistence, which is 
thought to occur at 2-4 weeks post-infection. Inaccessibility of the interior of the 
granuloma to antibiotic drugs is thought to contribute to drug tolerance of MTB in latent 
infection. As described below, reactivation oflatent TB infection can occur when the 
individual becomes immune-compromised due to illness or if the immune system is 
otherwise weakened. Active TB, either from a newly acquired infection or from 
reactivation of a latent infection, results in contagious spread of the pathogen to new 
human hosts. 
18 Inhalation 
90-95%: 
Latent Infection 
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5-10%: 
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Figure 1.2. The two major patterns of MTB infection. 
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An especially devastating problem associated with MTB in developing countries 
is the co-incidence ofTB and HIV infection [17]. TB is the leading killer ofHIV-positive 
individuals worldwide, accounting for approximately 23% ofHIV-related deaths [18]. 
The weakened immune system ofHIV-positive individuals is a key cause of increased 
co-morbidity. In individuals with latent TB infection who have healthy immune systems, 
there is a 10% chance that latent TB will "reactivate" and progress to active infection at 
some point during the individual's lifetime. However, in immune-compromised (e.g. 
HIV-positive) individuals the probability of reactivation increases to 10% per year [17]. 
To add to these alarming statistics is the recent emergence of drug-resistant strains 
ofMTB, which have evolved mechanisms of genetic antibiotic resistance [10]. These are 
designated multidrug-resistant tuberculosis (MDR-TB), which refers to MTB strains 
resistant to the two most common anti-tuberculosis drugs (isoniazid, INH, and rifampicin, 
RIF), and extensively drug-resistant tuberculosis (XDR-TB), which refers to strains that 
are resistant to INH and RIF as well as second-line antibiotics (e.g. kanamycin) and 
fluoroquinolones [ 1]. Incomplete treatment of latent TB infections has been identified as 
a major factor underlying the emergence of drug-resistant MTB strains, and further 
underscores the need to understand mechanisms of phenotypic drug tolerance in MTB 
pathogenesis. 
Subsection Two: MTB Persistence, Dormancy, and Drug Tolerance 
MTB' s ability to enter a state of non-replicating persistence is a major cause of its 
success as a human pathogen [9]. This phenomenon is thought to be an adaptive response 
of the organism to host-mediated stresses, which include hypoxia (low oxygen 
availability), nutrient starvation, high carbon monoxide (CO) and nitric oxide (NO) 
concentration, and acidic pH [19-23] . These environmental cues cause a dramatic 
response in MTB that involves coordinated transcriptional regulation ofhundreds of 
genes as well as numerous metabolic changes [24]. This response is at least partly 
mediated by the transcriptional regulator DosR (R v3133c ), which has been termed the 
"master regulator" of dormancy and which controls a regulon of ~50 MTB genes [25, 
26]. DosR, whose name in fact stands for "Dormancy survival regulator," was shown to 
be critical for viability of MTB cultures grown in in vitro hypoxia models, and loss of 
viability in DosR knockout strains of MTB was shown to coincide with loss of induction 
ofDosR regulon genes [27, 28]. The gene HspX (Rv2031c), also known as acr (alpha-
crystallin), is the most strongly-induced gene in the DosR regulon and has been studied 
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as a surrogate, or indicator, of the DosR regulon in general [26, 29, 30]. The work 
described in Chapter Four of this dissertation measures HspX transcription in response to 
stresses. While DosR has been thought of as the primary regulator of the hypoxic 
response in MTB, in fact nearly one-third of all MTB genes exhibit transcriptional 
changes in response to hypoxia [24], and a 2009 study found that DosR regulon induction 
was shown to be inessential for drug tolerance under hypoxic conditions in vivo and in 
vitro [31]. These findings suggest that our understanding of MTB' s adaptations to host-
induced stresses, and the state of the organism during non-replicating persistence and 
dormancy, are incomplete and require further investigation. A better understanding of 
how MTB dormancy in the host specifically relates to drug tolerance would help guide 
7 
the development of drugs targeted to dormant MTB, which could enable shortened 
antibiotic treatment regimens for active and latent TB infection. 
Subsection Three: Insights from the MTB Regulatory Network 
The regulatory mechanisms underlying MTB's adaptive response to host-induced 
stresses are still unknown, largely because we lack a comprehensive understanding of the 
MTB regulatory network. As such, only a small fraction of the > 180 MTB transcription 
factors (TFs) have validated functionalities, and the interactions between TFs- necessary 
for the regulation of complex behavior- have not been studied. To address these issues, 
the Galagan lab recently used ChiP-seq based techniques to construct the first genome-
scale map ofthe M tuberculosis regulatory network (Figure 1.3) [24]. 
Figure 1.3. ChiP-Seq based 'hairball' model of theM. tuberculosis transcriptional 
regulatory network. TFs and genes are represented as circles and regulatory interactions 
are represented as lines. 
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ChiP-Seq is the shorthand name for an in-vivo method of identifying genome-
wide binding sites of a transcription factor, entailing Chromatin IrnrnunoPrecipitation 
followed by DNA Sequencing [32]. In this procedure, a protein of interest is crosslinked 
to genomic DNA, which is then sheared into fragments of about 1,000 base pairs, or 1 
kilobase (kB). Because the protein preferentially binds to its sequence-specific binding 
sites, fragments containing these sites will contain a protein-DNA complex. Then, in the 
irnrnunoprecipitation step, these complexes are filtered out using an antibody for the 
protein of interest. Once filtered, the DNA-protein complexes are unlinked and the DNA 
fragments are sequenced, showing where in the genome the protein was bound. This 
method allows for extremely high redundancy and enables very high resolution: in other 
words, it allows researchers to pinpoint with high precision all the locations in the 
genome that are recognized and bound by the protein. By repeating this process for many 
transcription factors in the network, a reconstruction of the organism's regulatory 
network topology emerges. Many of the TFs identified by this work have analogous 
genes in M. smegmatis, which makes them amenable for study in biosafety level1 (BSL-
1) facilities. Intriguingly, this work [24] identified a regulatory subnetwork linking 
between hypoxic adaptation, cholesterol degradation, and lipid biosynthesis, through the 
regulators Rv0081, Rv3024, Rv3133c (DosR), and Rv3574 (KstR). Additionally, this 
work identifies network motifs such as feed-forward loops [33]that have been shown to 
underlie dynamic behavior in regulatory networks [34, 35]. The work described in 
Chapter Three of this dissertation was undertaken in an attempt to further explore the 
predictions of this regulatory network model, and to provide direct confirmation of 
regulatory interactions predicted by ChiP-Seq and microarray datasets. 
Section Two: Quantitative, Real-Time Measurements of Single Cells 
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Quantitative, real-time measurements of single cells provide dynamic information 
that can be helpful for elucidating mechanisms underlying cellular phenotypes and 
processes, because they provide information that is impossible to obtain via steady-state 
measurements of a bulk population average. Measuring the fluorescence intensity from a 
bulk flask culture, with a concentration of 106-109 cells/mL, reveals nothing about the 
fluorescence activity of individual cells. Two specific advantages of single-cell 
measurements are the ability to study phenotypic heterogeneity in a population, and to 
obtain a clearer understanding of dynamic processes (e.g. stress adaptations, or cell 
division). The importance of each of these phenomena is described here using specific 
examples from the literature, in order to put this dissertation work in context. 
Subsection One: Phenotypic Heterogeneity In Single Cells 
Phenotypic variation is a widespread phenomenon in bacteria, and has been 
shown to play a functional role in maintaining population fitness [36]. Isogenic microbial 
populations exhibit considerable cell-to-cell phenotypic heterogeneity, allowing some 
cells to survive environmental stresses that would otherwise eradicate the entire 
population [3 7]. Heterogeneity in a population can occur as a single Gaussian distribution 
or as a multimodal distribution comprising subpopulations (the size of which might be 
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similar or quite different). This heterogeneity can arise due to stochastic fluctuations in 
cellular components, transcription rate differences, variations in cell age or growth stage, 
and regulatory architecture such as feed-forward loops that are highly sensitive to small 
imbalances and lead to bistability [38-40]. These mechanisms result in the formation 
distinct subpopulations of bacteria within a clonal population [ 41, 42]. Importantly, 
discovering these heterogeneities is difficult via many methods (e.g. global 
transcriptional profiling via microarray [ 43]) because these assays necessarily involve 
taking a population-average measurement, which masks cell-to-cell variation [ 44]. 
Recent methods such as flow cytometry can sort cells into a small number of sub-
populations based on fluorescence measurements, but are limited in their ability to 
monitor live cells [ 45]. Microfluidic devices, however, offer a way of quantitatively 
measuring differences in gene expression, cell morphology, and cellular behavior (e.g. 
differentiation) in live cells, and offer in vivo-like microenvironments. These devices are 
thus uniquely well suited for studies of phenotypic variation. 
Of particular relevance to this thesis work is the finding that phenotypic 
heterogeneity in a microbial population is a key mechanism of persister formation [3 7]. 
Sub-populations of antibiotic-tolerant 'persister' cells have been observed in every 
pathogen yet investigated, including MTB, and are a major cause of refractoriness in 
bacterial infections [5, 6]. Importantly, the drug tolerance of persister cells is not due to a 
genetic change, but is rather a reversible phenotype [6]. For example, one mechanism of 
persister formation involves variable cell-to-cell expression of stress-response genes (e.g. 
HipA and RelE) [ 46-48]. Recent work has shown a clear link between single-cell 
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variation and drug tolerance in Mycobacteria species [ 49-51]. Aldridge et al. showed that 
M smegmatis cells generate cell-to-cell variability in size and growth rate; these 
differences were correlated with susceptibility to antibiotics targeted to cellular growth 
processes [ 49]. Wakamato et al. observed that M smegma tis cells exhibit stochastic 
'pulses' in expression ofKatG, an enzyme that activates the prodrug isoniazid (INH). 
These pulses resulted in cell-to-cell variation in KatG expression levels, which affected 
INH-mediated cell death [50]. These studies suggest that cell-to-cell heterogeneity is 
potentially an important determinant ofMTB drug tolerance, and investigating 
Mycobacteria at the level of single cells was critical for obtaining these results. Drug-
tolerant microbial persisters highlight the need to investigate single-cell phenotypic 
variation as a source of population-level antibiotic tolerance. 
Subsection Two: Dynamic Processes in Single Cells 
Cells employ multiple levels of regulation to coordinate gene expression, with 
regulatory network topology defining complex patterns of expression in regulated genes. 
Gene expression patterns, then, are dynamic responses to transient and fluctuating 
stimuli. These responses are regulated by multiple TFs, and as such are governed by 
regulatory elements including feedback, delay, logic gates, and autoregulation, and 
epigenetic factors such as post-transcriptional modification. To get a complete picture of 
regulatory dynamics thus requires the acquisition of quantitative data from single cells 
over time, rather than obtaining a population average measurement at only one timepoint. 
Examples of both positive and negative feedback elements are pervasive in biology, with 
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diverse functional roles being ascribed for these subnetwork architectures [52, 53] . In 
MTB, evidence exists to support the idea that the TF DosR may in fact function as a 
bistable switch, as it positively autoregulates its own promoter [54, 55]. This finding has 
implications for the dynamics ofMTB's entry into dormancy in response to host-induced 
stresses, as bistable network elements naturally give rise to diverse cellular phenotypes. 
Additionally, functional roles for high-amplitude, low-frequency 'pulsing' in genetic 
circuits have been reported in prokaryotic and eukaryotic regulatory networks [56]. 
Finally, the dynamics of cellular responses to stress are most appropriately studied in 
single cells due to asynchronous response time in single cells, and the possibility of 
differential responses across a population. Microfluidic platforms for single-cell analysis 
of Mycobacteria species are uniquely well suited to study adaptations to stresses due to 
the capabilities of the platform for environmental control; in Chapter Five some potential 
future directions for this work are explored. 
In summary, copious examples from diverse bacterial organisms (including MTB) 
and eukaryotes point to the need for quantitative and dynamic measurements of single 
cells in order to more accurately model dynamic processes, recapitulate predictions of 
computation regulatory network models, and quantify the extent and possible 
significance ofheterogeneous phenotypes within a population ofisogenic cells. 
Microfluidic devices offer an attractive solution for this problem because they allow live-
cell imaging of individual cells over multiple cell cycles with fine control over 
environmental conditions. Chapter Two describes the methods used to design and 
fabricate such a device for Mycobacteria, the first of its kind specifically designed for 
studies of this organism. 
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CHAPTER TWO: A Microfluidic Platform for Live-Cell Imaging of Mycobacteria 
Microfluidic devices have become popular tools for systems biology studies 
because they enable fluorescence data to be gathered, simultaneously and independently, 
from many individual cells over long time periods. Researchers have recently employed 
these devices in conjunction with time-lapse microscopy systems to study prokaryotic 
and eukaryotic organisms [53, 57]. The advantages of this technique include the ability to 
measure and quantify cell-to-cell heterogeneity and dynamic processes, as described in 
Chapter 1, and exquisite environmental control [52]. In particular, several groups were 
able to gain novel insights into biological processes in E. coli using microfluidic time-
lapse microscopy platforms [58-60]. However, before this thesis work began, there 
existed no analogous studies reporting the successful trapping and culture of 
My cobacteria on-chip. This Chapter describes efforts to build such a device and to 
optimize it for use with M smegmatis. 
Section One: Microfluidic Device Design and Fabrication 
In designing a microfluidic cell-trapping device for Mycobacteria species, the 
materials selection process was guided by previously published reports describing the 
successful use of poly( dimethylsiloxane) (PDMS)-based microfluidic devices bonded to 
glass for live-cell imaging [61-63]. Design criteria for microfluidic cell-trapping devices 
include the following: (1) cells must remain stationary in the x, y, and z-planes for the 
duration of the experiment; (2) growth conditions of the cells (such as temperature and 
C02 content) must be met and maintained; (3) the device must not interfere with 
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fluorescent image capture; and (4) fine control over the cells' environment, such as the 
ability to change the concentration of a chemical in the medium, is required for more 
complex experiments. The advantages of PDMS for this application include its optical 
transparency, gas permeability, low cost, and relative ease ofprototyping. Using 
photolithography techniques for patterning SU-8 photoresist onto silicon, a device mold 
can be generated from a pattern designed in AutoCAD in <24 hours. This silicon mold 
may then be used to generate many copies of the PDMS device. This Section provides an 
overview of these device fabrication processes: namely, 'hard lithography' using SU-8 
and silicon, and 'soft lithography' using PDMS and glass coverslips. 
Subsection One: Microfabrication in SU-8 and Silicon 
Microfabrication techniques including photolithography (literally "writing with 
light") were originally developed by the electronics industry and have now found 
widespread use in biomedical research [64]. Ultraviolent (UV) photolithography involves 
user-defined patterning of a UV-sensitive material known as photoresist. The photoresist 
SU-8 exists as a viscous liquid until it is exposed to ultraviolet light, at which point it 
solidifies due to chemical crosslinking. By employing an opaque stencil known as a 
photomask to specify areas ofUV crosslinking, the researcher can thus can create 
patterns of solid SU-8 features with micron-scale dimensions [65] . This process is 
typically performed on a flat silicon wafer in a Class 1000 cleanroom. The SU-8 
photolithography protocol is briefly summarized below; detailed protocols are published 
in the SU-8 user documentation [66]. The description provided here focuses on those 
steps in the protocol that are most critical for achieving the sub-micron feature heights 
necessary forM smegmatis cell trapping. An overview of the entire process is 
diagrammed below in Figure 2.1. 
STEP 
Deposit SU-8 
on silicon wafer 
1 
Align mask; expose to UV 
1 
Develop f~atures 
1 
Pour PDMS 
onto SU-8 mold 
1 
Allow PDMS to cure 
1 
Peel off PDMS 
1 
Cut out PDMS device 
and bond to glass 
3-D VIEW 
Figure 2.1. Process for making PDMS microfluidic devices from an SU-8 mold. 
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SU-8 polymer is sold in various formulations that differ in their viscosity, such 
that coating a silicon wafer with liquid SU-8 and spinning the wafer at a defined speed 
(e.g. 3000 rpm) will result in a layer of uniform thickness. This process is known as spin-
coating, and the coating thickness depends heavily on the viscosity of the particular SU-8 
formulation in use. For example, in Figure 2.2 (reproduced from [66]) it can be seen that 
a spin speed of 2000 RPM will produce a 2.4-micron thick coating if SU-8 2002 is used, 
but the same spin speed will produce a 0.6-micron thick coating of SU-8 2000.5. Typical 
spin times for this process step are 30 seconds. 
SU-8 2000 Spin Speed vs. Thickness 
3.4 I I 
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- 2.0 +-----~----~-----~---~----=~-------1 ~1 .8 -- ----\- I . _ t_ 
a ~ :: : .. ~ : 1 
~ ~:~ ~----.. --~~------.---. t ---r-~-----· 
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0.2 I 
0.0 +------,.....----+----+----_,_---....---~ 
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Spin Speed (rpm) 
Figure 2.2. SU-8 f'dm thickness as a function of spin speed. Reproduced from [15]. 
After spin-coating, the wafer is placed on a 65°C and then a 95°C hotplate for 1-2 
minutes to allow evaporation of excess solvent. The SU-8 coated wafer is then placed in a 
UV mask aligner (Karl Suss) and exposed to UV radiation such that ~100 mJ/cm2 of 
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exposure energy is obtained. The precise exposure times vary from machine to machine 
and must be calibrated for the specific process due to such factors as bulb brightness, 
lifetime, and mirror cleanliness. In this work, four wafers were typically prepared each 
time a new device mold was being fabricated, so that adjustments to the UV exposure 
step could be made as necessary. 
After UV exposure, a 'post-bake' step is performed, again comprising of 1-2 
minutes oftreatment on a 65°C hotplate and then 1-2 minutes on a 95°C hotplate. This 
step is intended to accelerate the polymerization of the SU-8, and indeed the patterned 
features become visibly discernible at this step. Finally, the wafer is placed in SU-8 
developer solution (MicroChem) and agitated or shaken to dissolve un-crosslinked SU-8. 
For features in the 25-75 micron range, development may require 5-7 minutes of 
immersion, but for sub-micron features it is recommended to develop for only 5-10 
seconds at a time in order to avoid over-development and degradation of the features. 
After development, a "hard bake" step may be performed, which entails 10-30 minutes at 
150°C and further improves the mechanical properties of the SU-8 features. However, for 
submicron features to be used as a mold for PDMS devices, the hard bake is unnecessary. 
Subsection Two: PDMS Soft Lithography 
PDMS, also known as dimethicone, is a low-cost and optically transparent 
polymer with high gas permeability and native hydrophobicity, and as such is an 
attractive material for microfluidic devices for use with live cells [67, 68]. PDMS-based 
microfluidic devices can be fabricated using an SU-8 mold (as described in Subsection 
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One) as a master, via soft lithography techniques. PDMS consists of two liquid 
components- a polymer and a crosslinker- that solidify into an optically transparent, 
solid silicone rubber after mixing. This process is accelerated at high temperatures; 
therefore, when liquid PDMS is poured onto the SU-8 mold and baked at 80°C, solid 
devices can be peeled off the wafer in less than two hours, meaning that multiple 
'batches' ofPDMS devices can be fabricated per day from a single SU-8 mold. This 
transfer process has high fidelity in the feature size range applicable to this project (i.e. 
0.9 micron feature height, and 10-100 micron feature width); that is, wherever there were 
raised SU-8 features on the silicon wafer, analogous 'grooves' will be present in the 
PDMS. After curing, holes are punched through the device where access tubes will be 
needed during experiments; then, the patterned PDMS and a clean glass coverslip are 
bonded together using an oxygen plasma bonder. The plasma bonder creates free radicals 
in the exposed siloxane and silicon dioxide (glass) surfaces, which are then pressed 
together to form covalent bonds [69, 70]. This creates a watertight network ofPDMS 
microchannels, accessible via the inlet holes, bonded to the glass coverslip (Figure 2.3 
below). 
The power of using SU-8 and PDMS-based photolithography lies in its low cost 
and high throughput, allowing for very rapid proto typing of new device designs. The 
entire fabrication process, from AutoCAD design to functional PDMS device, can 
theoretically be performed in less than 48 hours. In addition, small device design changes 
(i.e. modifying the channel height) are performed at the SU-8 level and thus do not 
require a new photomask to be designed or fabricated, further simplifying the prototyping 
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process. A criticism of PDMS-based microfluidic devices is that their material properties 
render them unsuitable for field-based devices such as point of care diagnostics [71], and 
as such these devices are appropriate only for laboratory settings. For single-cell time-
lapse imaging experiments such as the work described in this thesis, however, PDMS-
and-glass based devices are entirely appropriate, and indeed the ease and low cost of 
these devices have made them a true enabling technology for single-cell biology studies. 
Figure 2.3. PDMS microfluidic device on a glass coverslip with channel architecture and 
inlet holes clearly visible. 
Section Two: Device Performance and Optimization 
As mentioned above, this thesis work began at a time when no demonstration of 
M smegmatis cell trapping had been reported in the literature; bacterial single-cell 
studies had focused on E. coli [72] or B. subtilis [ 40], but M smegmatis has distinct 
morphological characteristics that require optimization of the microfluidic cell trapping 
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device. Chief among these differences are the slow doubling time of M smegmatis and 
the waxy cell wall of this organism. Accordingly, cell trapping and media delivery 
protocols were continually updated and optimized over a period of~ 1 year to arrive at a 
protocol that worked reliably. Additionally, the device architecture itself was eventually 
changed drastically from the design used in initial experiments. This optimization process 
is described here, as well as the protocols for performing the live-cell time-lapse 
microscopy experiments. Other groups have now also begun to perform live-cell imaging 
studies in M smegma tis, fmiher validating the power of this technique [73]. 
Subsection One: Cell Loading and Trapping 
The initial device architecture used in this work was based on the Hasty et al. 
trapping device for E. coli described above [59]. The architecture of this device consists 
of a 3.0-micron high channel for media delivery, and a looping 'trap' region that is 
adjacent to the main media delivery channel and has a height of0.9 microns, 
approximately equal to the diameter of a single M smegmatis cell. A schematic of this 
device is shown in Figure 2.4 below (adapted from [59]). This device (and all other 
devices described here) was designed in AutoCAD and fabricated in PDMS from an SU-
8 mold as described above. In the earliest cell loading experiments, wild type M. 
smegmatis cells were loaded directly into this device, with no pre-wetting or "priming" of 
the microfluidic channels with media and with no pre-treatment of the cells other than 
filling a syringe with a culture of cells in mid-log phase growth (OD 0.5). 
Cell Inlet 
Media 
Inlet 
Heiaht: 
3.0 microns 
.,._Media 
Flow 
Waste Outlet 
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Figure 2.4. Architecture of the earliest microfluidic device used in these experiments, 
adapted from [59]. 
During cell loading, 7H9 media containing mid-log-phase cell culture was flowed 
via syringe, which was either depressed manually or connected to a programmable 
syringe pump (SyringePump.com) flowing at 20 uL/hour. In this phase, most cells flowed 
through the device without entering the trap region, but a few cells (<1 %) would enter the 
trap channel and remain immobilized there. After cell loading, the syringe was removed, 
and 7H9 media was flowed from the 'media inlet' at a slower rate of 5-l 0 uL!hour so that 
fresh nutrient media would flow into the trap channel while not dislodging cells trapped 
there. These experiments were performed at 37°C and a cell doubling time of3-4 hours 
was observed. Media switching was accomplished by manually switching between 
syringes feeding into the media inlet; experiments with Rhodamine fluorescent dye 
revealed that switching operations operated on a timescale of <1 minute (Figure 2.5). 
Figure 2.5 Rhodamine dye was flowed into the cell trapping region for 60 seconds and 
replaced with 7H9 media. 
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As seen in Figure 2.6 below, this early device was functional in that we were able 
to successfully trap live M smegmatis cells in the trapping channel using this device and 
cell loading protocol. However, the slow growth of M smegmatis combined with the 
waxy cell wall of this organism necessitated changes in the device itself and with the 
loading/trapping protocol. Although the waxy coating of M smegmatis allows for good 
adherence to PDMS channels, it also results in cells having a high affinity for each other: 
in other words, cells have a tendency to flocculate, or 'clump,' both when growing in 
liquid flask culture and when introduced into a microfluidic device [74]. This posed a 
problem for single-cell imaging, because the fluorescent signal from two clumped cells 
cannot be easily resolved and quantified. Another consideration apparent in Figure 2.6 is 
that the cells are sparsely distributed in the trapping channel. This is due to the device 
architecture: because the cells are not forced through the trapping channel, the vast 
majority will never enter this channel, and only a few cells will become trapped. With 
fast-growing E. coli, a sparsely populated microfluidic channel will grow into a dense 
monolayer within a few hours, so a low initial number of trapped cells is acceptable. 
However, since M smegmatis doubles every 3-5 hours, a relatively dense monolayer is 
required to get a meaningful population size for experiments. 
Figure 2.6 M. smegmatis cells in the trapping channel of the microfluidic device. This trap 
contains approximately 15 cells, whereas >30 cells are preferred for imaging experiments. 
To mitigate these issues, we developed a protocol for centrifuging and filtering 
cells prior to loading that ensured a high-density population of non-clumped cells for 
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trapping. Cells were grown to log-linear phase growth overnight in a flask; then, 5mL of 
culture were centrifuged at 3500 rpm for 5 minutes, and the pellet was re-suspended in 
1.5 mL of fresh 0.2-micron filter-sterilized 7H9 cell media. This created a dense culture 
volume, which was forced through a Sum syringe filter (Millipore) to break up any cell 
clumps. The OD after filtering diminished significantly, to 0.1, as most of the cells were 
trapped in the 5.0-micron filter. 
Although the Hasty-based device functioned well as a cell trap, persistent issues 
existed with regards to maintaining growth conditions for long time periods in the device. 
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Because PDMS is a compliant material, hydrostatic pressure dissipates along the length 
of a PDMS microchannel. The pressures required to do this resulted in high enough flow 
rates at the cell trapping region of the device that it was difficult to maintain an 
immobilized monolayer of cells in the trapping region. This problem was compounded by 
the waxy, adherent cell coating of M. smegmatis, which led to a large number of cells 
adhering to channel walls throughout the device, not just in the trap region. Finally, the 
sub-micron channel heights required to create a true 'monolayer' of cells resulted in 
PDMS channels that were prone to collapse, because the channels had a width:height 
ratio exceeding the maximum 15:1 aspect ratio reported for PDMS channels [67]. 
In order to mitigate these issues we designed and fabricated a device loosely 
based on a commercially available microfluidic cell trap (CellAsic Corp.) in which the 
trapping channel is a component of, rather than an adjacent offshoot from, the main flow 
channel (Figure 2. 7), which forces all cells through the trapping region of the device and 
results in faster and more efficient cell trapping. This trap region is 0.8 microns in height, 
which allows for some degree expansion ofthe PDMS channel due to hydrostatic 
pressure from fluid flow and thus maintaining a true 'monolayer' of immobilized cells. 
The increased trapping efficiency of this device rendered the cell centrifugation step 
unnecessary, and the centrifugation step was removed from the cell loading protocol. To 
prevent collapse of the 0.8 micron height trapping channels, support posts were designed 
into the device to maintain an aspect ratio of 10:1 in the trapping channels. Also, the 
length of the channels was shortened from 2cm to 0.8cm, to minimize pressure 
dissipation along the channel length. 
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Figure 2. 7 shows a diagram of the microfluidic device architecture that was used 
for all experiments from 2011 onward. The dimensions of the channels in the trapping 
region are 1200 microns (1.2mm) wide, 2000 microns (2mm) long, and 0.8J..Lm tall, with 
support posts spaced every 15 urn to prevent channel collapse. Outside of the trapping 
region, the device is 3.5J..Lm tall, which helps avoid clogging of channels, and the width 
and length of these channel segments are 1.5mm and 4mm respectively. Support posts are 
placed throughout these channels as well, but are not shown in Figure 2. 7 in the interest 
of visual clarity. Media delivery is accomplished via syringes that are actuated by a 
programmable syringe pump and set to 5 J..LL!hour flow rates, and media switching can be 
accomplished by alternative between syringes containing different media formulations as 
described above. Due to these changes, the new device architecture is robust and offers 
easier cell trapping as well as live-cell culture capabilities. The data shown in Chapters 3 
and 4 was obtained using this device architecture unless otherwise noted. 
Cell Inlet Media Inlet 
60X 
Channel height: 3.5 microns 
Trap height: 0.8 microns 
Figure 2. 7 The CellAsic-style cell trapping device resulted in improved cell trapping 
efficiency. 
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Subsection Two: Live-Cell Imaging 
The experimental protocol for acquiring time-lapse images was performed as 
described below, following standard procedures for time-lapse fluorescence microscopy 
[53, 75]. Deviations from this general protocol were rare, and for the data presented in 
this dissertation the time-lapse protocol followed this method unless otherwise noted. 
After cells were loaded into the microfluidic device, they were allowed to grow for 1 
hour without any fluorescence image acquisition. This step allowed the cells time to 
"acclimate," i.e. to recover from any stresses related to filtering/loading, before exposing 
them to high-intensity fluorescent light, which can be phototoxic to live cells [75]. In our 
experiments it was observed that cell growth was slowed when fluorescent acquisition 
was begun immediately after cell loading, especially at short excitation wavelengths, e.g. 
440nm for imaging of cyan fluorescence protein (data not shown). Phase contrast images 
were taken every 5-15 minutes over this time period to ensure that cell growth was 
visible and to monitor the on-chip conditions before continuing the experiment. 
After the one-hour incubation following cell loading, brightfield images were 
acquired every 15 minutes and fluorescence images were acquired every 30 minutes. 
When automated image acquisition and shuttering was available (i.e. in all experiments 
performed from 2011 onward), these images were acquired automatically using the 
timelapse imaging functionality ("Acquire 6D") included with the Nikon NIS-Elements 
imaging software. Exposure time varied between experiments depending on the 
microscope and fluorescence channels used, but was kept consistent between related 
experiments (i.e. experiments measuring the same strain or phenomenon). In this 
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dissertation, the acquisition times are reported for each experimental dataset. As 
described above, device temperatures were maintained at 3 7 degrees Celsius for the 
duration of all experiments; this temperature was verified using a thermocouple and each 
microscopy system was calibrated individually. 
_....., . 
.,. ----..,.---------- ... ~ ~ ... f® • e I ~ ' 4- ! - - ..-. ... -II£· 
Acquired image 
{Brightfield and 
Fluorescence) 
-_,._ 1--... - EJ 
I -- II""• El@ 
®.-- o-- • I•• El0 0 
- ..... 1 .. - El - ·lLl'C 
--· 
- 1"'- I 
Camera 
Settings 
t: l• --......... -- ~.-....... _ ..... ---- - --·--· ~......... - - · ---- ---1 
k l......., I 
0G- lr • ..,.,. lr § z..,.. til .-.-
-- + l .,tJ I H i x ~ 
,_ - - .. -ro=-
Pin IS* • . ...... • B 
g_ _ --- -
---· -·--------------1 
~=.-=.::::,.:..,_..;.o---·-
~~~ ~~ 
Experiment Protocol 
Figure 2.8 Screenshot ofthe NIS-Elements user environment during a typical timelapse 
experiment. 
A screenshot of the NIS-Elements imaging software during a typical experiment 
is shown above in Figure 2.8. A dialog box allows the user to control camera settings 
such as exposure time, binning, and visual gain. The "ND Acquisition" dialog box allows 
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for automated experiments to be set up, with control over fluorescence channel, X-Y 
multipoint imaging, auto focus, acquisition interval, and Z-stack images. If macros such at 
autofocus algorithms or simple "wait" steps are desired, they can be programmed and 
integrated into the ND Acquisition functionality as well. Finally, a live view of the stage 
(or the last image acquired) is visible, and the brightness/contrast settings for brightfield 
and fluorescence channels can be manipulated individually. Thus each dataset results in a 
multi-channel timelapse image file (.nd2 format) that can be subsequently analyzed in the 
image analysis software ImageJ and/or other image analysis functions in MATLAB, as 
described in Section Three. 
Section Three: Image Segmentation and Analysis 
As described in Section Two, data from each time-lapse microscopy experiment 
was obtained in the form of a multi-channel fluorescence image file in .nd2 format, 
containing raw image data for each fluorescence acquisition channel at each timepoint. 
This section describes the MA TLAB and ImageJ -based tools that were developed and 
used for this work [76, 77]. These tools include MATLAB functions developed in the 
Galagan lab by Wen-Han Yu and Jason Keller, as well as the open-source software tools 
Miji and MicrobeTracker, which were developed by other groups [78, 79]. Together, 
these tools constitute a modular and automated pipeline for extracting and visualizing 
quantitative information about single-cell morphology, growth, division, lineage, and 
fluorescent protein expression from the .nd2 files obtained in these time-lapse imaging 
experiments. See Appendix for all code described in this Section. 
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Subsection One: Image Processing with Miji 
In order to prepare raw .nd2 files for image segmentation in MicrobeTracker, 
basic processing steps including image registration (i.e. alignment) and background 
subtraction must be performed. This can be accomplished via the MA TLAB program 
Processlmage_byJ.m, originally written by Wen-Han Yu and modified by Jason Keller. 
This program takes as input a raw .nd2 file and parameters indicating which fluorescence 
channels were acquired during the timelapse experiment. The program proceeds in four 
steps, using the open-source software Miji to interface directly with ImageJ at each step. 
Step 1 opens the .nd2 file and organizes each fluorescence channel into a separate folder, 
with each timelapse image frame saved as a separate .tif. For example, for an .nd2 file 
with 60 frames in brightfield and in GFP fluorescence, Step 1 will create folders called 
'BF' and 'GFP', each containing 60 .tifimages. Step 2 uses the ImageJ function 
StackReg to align the frames of each image stack, which corrects for frame-to-frame jitter 
and image drift and is critical for subsequent cell segmentation. In Step 3, a background 
subtraction operation is performed on all images to further aid in cell segmentation by 
increasing contrast. Finally, Step 4 creates a single .tiffile for each image stack, e.g. one 
file called 'BF.tif containing all60 processed brightfield frames and one file called 
'GFP.tif containing 60 processed GFP image frames. These multiframe .tiffiles can be 
directly read by MicrobeTracker in the downstream processing steps. Thus, the function 
Processlmage_byJ.m is a simple tool to automate several image processing steps that 
could otherwise be performed manually in ImageJ, but at the possible expense of 
uniformity, accuracy, and speed. 
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Subsection Two: MicrobeTracker 
MicrobeTracker is an open source software tool developed at Yale University for 
the purpose of segmenting images of bacterial cells [79]. It is designed to outline and 
track rod-shaped bacilli over the course of a time-lapse image series, and to store 
quantitative information about the morphology, growth, division, lineage, and 
fluorescence intensity of each individual cell. The software runs in MA TLAB and can be 
modified for optimal performance based on the shape parameters of the cells and other 
characteristics of the images (e.g. brightness, contrast, and magnification). 
A screenshot of the MicrobeTracker program in use is shown below in Figure 2.9. 
A frame of a brightfield image series is displayed the main window of the program, with 
a monolayer of rod-shaped cells as well as circular PDMS support posts visible. The cells 
have been automatically traced by MicrobeTracker, and these traces appear as white 
outlines. Each cell is numbered, and the information panel at the bottom-left indicates 
that 104 cells were traced in total across the 53 image frames. Also displayed in this 
information panel is information regarding the current frame (19 of 53), the currently 
selected cell (Cell 23 of 1 04), and some information about the currently selected cell. 
Using this interface, the user can automatically trace all cells in each image frame and 
manually correct any cells not correctly traced or identified by the program. The program 
saves all information to a .mat file that stores all the data for each cell analyzed. This file 
can then be processed in MA TLAB to generate single-cell fluorescence plots and all 
other graphs, as described in Subsection Three. 
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Figure 2.9. Screenshot ofMicrobeTracker program. Cell23 is marked by the black arrow. 
Subsection Three: MATLAB Processing/Analysis 
Once the .mat file containing all cell information for a given timelapse experiment is 
generated in MicrobeTracker, the data must now be extracted for further processing by 
subsequent MATLAB programs. The program getCellTrace.m was written by Jason 
Keller for this purpose. getCellTrace.m employs a switch-case loop to store information 
not encoded by MicrobeTracker, such as the fluorescence acquisition time interval, 
experimental conditions (e.g. antibiotic concentration), and the locally-stored data path of 
the results file. The program can thus be called using an experimental ID number, e.g. 
'02-04-14' , which matches the '02-04-14' case in the switch-case loop. The output of this 
program is two cell arrays, "CellFluore" and "ExptData," which are leaner data structures 
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than the results file and which encode all relevant cellular and experimental information. 
The program getCellTrace.m can therefore be thought of as a data-cleaning step that can 
be modified based on the specific needs of the researcher while keeping the 
MicrobeTracker output file intact. 
A group of modular analysis/plotting functions were written by Wen-Han Yu and 
Jason Keller to perform specific operations on the single-cell data structures and generate 
the graphs presented in this dissertation. As a representative example, the function 
DrawGrowthRate.m creates two figures based on the data in CellFluore and ExptData: 
the first figure plots the length of each individual cell over time, and the second figure 
plots the average growth rate of the population as a function of time. The user can specify 
only a subset of cells to be analyzed, e.g. for comparing the growth behavior of cells that 
survived drug treatment vs. cells that lysed or died. The graphs generated by this program 
for a representative experiment are displayed below in Figure 2.1 0. Plot information such 
as the title, number of cells plotted, and drug treatment time is automatically generated 
from the information contained in ExptData, allowing for streamlined and uniform 
processing of each experimental datastet. 
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Figure 2.10 Screenshot showing output ofDrawGrowthRate.m. 
Additional MA TLAB functions were written to generate plots of information such 
as single-cell fluorescence intensity, the number of fluorescence 'peaks' for each cell 
during an experiment, and live/dead statistics for each experiment. These functions are 
not described in detail here, as they operate similarly to DrawGrowthRate.m, but the 
figures in Chapters 3 and 4 were created using these functions. Together, the 
computational tools described in this Section form an automated image processing 
pipeline that is simple to use, fast, accurate, and modular, in the sense that it can be easily 
adapted for new functionalities as needed simply by writing additional plotting or 
analysis scripts. Indeed, several such scripts were created over the course of this thesis 
work (e.g. the fluorescent signal peak-counter function described above), and the time 
required to create a new plotting function was approximately 4-8 hours on average. 
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Section Four: Molecular Cloning in M. smegmatis 
Demonstrating the ability to trap and culture live M smegmatis cells in a 
microfluidic device for >24 hours was an essential milestone for studying cellular 
behavior of M smegmatis in real-time. Concurrently, molecular cloning work in M 
smegmatis was performed in order to generate engineered strains containing genetically 
encoded fluorescent protein (FP) reporter molecules for genes of interest. This Section 
summarizes the methods used to generate strains of M smegmatis for the experiments 
described in this dissertation. 
Subsection One: Description of Protocols 
In general, the protocols described here follow standard molecular cloning 
practices and references [80, 81]. Cloning protocols designed specifically for 
Mycobacteria are modified slightly versus those used with E. coli due largely to the 
reduced permeability of the mycobacterial cell membrane and the slow growth of 
Mycobacteria species; for the methods described herein that are specific to Mycobacteria, 
protocols were followed according to the handbook Mycobacteria Protocols [82] . 
Primers were designed using genomic sequence data taken from TBDB (tbdb.org) 
or NCBI databases (http://blast.ncbi.nlm.nih.gov/) . All primers were ordered from 
Integrated DNA technologies (http://idt-dna.com/) with appropriate restriction enzymes 
chosen based on the plasmid backbone; this analysis was performed using ApE 
(http: //biologylabs.utah.edu/jorgensenlwayned/ape/). Primers were used to amplify 
genomic DNA using standard polymerase chain reaction (PCR) methods [81]. PCR 
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products were visualized on a 0.1% agarose gel and the correct size band was excised and 
purified using the Qiagen gel extraction kit, and all DNA digestions and ligations were 
performed using standard Qiagen kits and protocols (http://www.qiagen.com/). Ligation 
products were again PCR amplified for increased concentration and purity before being 
digested and ligated into vector backbones. Vectors containing the plasmid insert were 
transformed into the competent E. coli Top 10 strain using standard heat-shock 
transformation protocols ( 42°C for 60-75 seconds followed by 1 hour of recovery at 
3 7°C) and cells were plated and screened using antibiotic-LB agar plates. 
Plasmid DNA from screened E. coli colonies was collected using Qiagen kits and 
procedures (www.qiagen.com/) and verified by sequencing (www.macrogenusa.com/) 
before being transformed into electrocompetent M smegmatis using standard 
electroporation protocols as described in [82]. M smegmatis transformants were screened 
on antibiotic-LB or antibiotic-7H9 agar plates. For strains containing fluorescent protein 
constructs, fluorescence was verified via fluorescent emission measurements using a 
Tecan Infinite 200 microplate reader (http://www.tecan.com/) and/or a fluorescent 
microscope with the appropriate filter settings (Nikon). 
Subsection Two: Inducible Promoter Systems and Fluorescent Protein Constructs 
There now exist numerous systems of exogenous control of gene transcription in 
living cells, in prokaryotes as well as eukaryotes [83]. These are known as inducible gene 
expression systems because they allow for reversible control of gene expression via the 
addition of an inducer chemical. The Tet, or tetracycline-controlled, expression system 
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(Clontech) is an inducible promoter system that is responsive to the antibiotic tetracycline 
and its derivatives (e.g. doxycycline) [84]. In this system, a promoter containing 
tetracycline-responsive elements is cloned upstream ofthe gene of interest. Also cloned 
into the cell is a vector that constitutively expresses the TetR protein, which can be an 
activator (Tet-On) or a repressor (Tet-Off). When anhydrous tetracycline (aTe) is 
introduced into the cell culture medium, the aTe molecules bind to the Tet protein, 
causing a conformational change that allows it to bind to the Tet-responsive elements in 
the gene of interest's promoter. In the case of the Tet-On system, this complex then 
recruits RNA polymerase to the promoter, "turning on" transcription of the downstream 
gene. These systems have been shown to enable exogenous control of gene regulation 
over two orders of magnitude in Mycobacterium smegmatis as well as in MTB [84]. A 
further advantage of the Tet system is low basal transcriptional levels in un-induced cells 
(i.e. low 'leakiness' of the system). 
We employed Tet-inducible systems to facilitate the study of transcription factor 
activity in M smegmatis at the single-cell level in a rnicrofluidic platform. Using the 
molecular cloning procedures outlined in Subsection One, our group designed and 
constructed strains of M. smegmatis where the TF KstR is under transcriptional control of 
the Tet-On system, such that the TetR protein binds to the TetO promoter and inhibits 
transcription ofKstR except when aTe is present (i.e., addition of aTe 'turns on') KstR. 
These strains were designed and constructed by Suma Jaini. We also cloned green 
fluorescent protein (GFP) into the vector downstream ofKstR, so that we can measure 
GFP production as an analogue for KstR's production. A hygromycin resistance vector 
ensures the ability to maintain this vector in cloned cell populations. 
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Figure 2.11 . Representative plate-reader and microfluidics experiments showing repeated 
transcriptional activation of Tet-KstR-GFP in response to ATC addition (50 ng/mL). 
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We verified the performance of the Tet-driven KstR-GFP system using plate 
reader measurements (Tecan) and in single cells using our microfluidic live-cell imaging 
platform, as shown above in Figure 2.11. In both the plate reader and microfluidics 
experiments, addition of aTe causes a 4-fold increase in relative GFP fluorescence within 
2 hours of ATC addition. In the absence of aTe, KstR production (and thus, GFP 
fluorescence) is negligible, and a Clp proteasome degradation tag targets the KstR-GFP 
for degradation [85, 86]. In the microfluidics experiment, media switching was performed 
by manually switching between syringes containing 7H9 media with and without ATC 
(50 ng/mL in the experiment shown in Figure 2.11) as described above. This was 
performed on the fly during experiments and did not dislodge cells from the trap region. 
These initial experiments served to validate the performance of our inducible promoter 
and fluorescent protein constructs, and formed the basis of the strains that were 
engineered for the experiments described in Chapters Three and Four. 
Subsection Three: List of Strains 
A list of the strains and plasmids used in this work is given below in Table 1. The 
E. coli strain used for all cloning was the Top 10 strain (Invitrogen). M. smegma tis clones 
were constructed from a wild-type mc2 155 strain [87]. Plasmids were based on the 
episomal plasmid PMV261 or the integrating plasmid PMV306, and the strain used for 
each experiment in the text is indicated [88]. 
It is important to note that because the episomal plasmid PMV261 is not 
integrated into the chromosome, it may be present at a different copy number in different 
cells. This precludes quantitative comparison of cell-to-cell heterogeneity in gene 
expression. Therefore, the integrating plasmid PMV306 was used in this work except 
where noted. This plasmid integrates at the chromosomal att site using an int phage 
integrase, and is thus present at a copy number of exactly 1 in every cell. For example, 
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Figure 2.12 below shows a schematic of the HspXp:ECFP reporter construct in the 
integrating PMV306 plasmid with hygromycin resistance. Additionally displayed in this 
schematic is the Pstl restriction site used during cloning, the E. coli origin of replication 
OriE, and the int sequence for integration into theM smegmatis genome. 
Pst1 4414 .. 4419 
HspX promoter 3910 .. 4410 
pMV306-Hygro HspXp:ECFP 
5274 bp 
Figure 2.12. Schematic of a PMV306 integrating vector used in this work. 
- - - ------
Table 1. Mycobacterial strains and plasmids used in this work. 
Strain/plasmid Description Reference or source 
Strains 
M smegmatismc2 155 Wild Type [87] 
M smegmatis KGl/6038-2 b.KstR::Zeocinr, This study 
pKG1, p6038-2 
E.coli Top10 General cloning strain Invitrogen 
Plasmids 
pMV306H Hygr [88] 
pMV261K Kanr [88] 
pWOscKC1953 pMV261K derivative, Yu et al. 
P nit/tet-N i tR-m, (manuscript in 
P nit/tet-TetR-f, preparation) 
P nit!tet-KstR-RFP-m, 
PMI9s3-YFP-s 
pWOscKC6038 pMV261K derivative, Yu et al. 
P nit/tet-NitR-m, (manuscript in 
P nit/tet-TetR-f, preparation) 
P nit/tee KstR-RFP-m, 
PM603s-YFP-s 
JK306H pMV306H derivative, This study 
PMHspx-ECFP 
pKGl pMV306H derivative, This study 
Ptet-KstR-RFP-m 
p6038-2 pmV261K derivative, This study 
PM6o3s-GFP-s 
pNar:ECFP pmV261K derivative This study 
f: fast proteasome degradation tag; m: medium degradation tag; s: slow degradation tag. 
PM1953: Intergenic region upstream ofMSMEG 1953. 
PM6038: Intergenic region upstream ofMSMEG 6038. 
PMHspX: Intergenic region upstream ofMSMEG 3932. 
pNar: Integenic region upstream of E. coli gene narG (ECK1218). 
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CHAPTER THREE: Quantitative Time-Lapse Imaging of M. smegmatis Cells 
As described in Chapter 1, the main advantages of a single-cell time-lapse 
imaging platform include the ability to extract quantitative data about diverse cellular 
parameters (e.g. gene expression, growth, morphology, lineage, cell fate), simultaneously 
and with high throughput, and to use this data to more accurately model or understand 
dynamic processes within single cells and to observe to what extent heterogeneity in 
these parameters exists within a population of cells. After individually validating the 
separate components of our experimental platform - the microfluidic cell trap itself, the 
fluorescent M smegmatis strains, the live-cell microscopy system, and the automated 
image analysis pipeline- we used the platform to address several questions of this nature, 
the results of which are discussed here and in Chapter 4. 
Using our platform, we analyzed in real-time the functional relationship between 
the transcription factor KstR and two of its computationally predicted gene targets, 
resulting in what is, to our knowledge, the first direct measurements ofTF-target 
interactions in single M. smegmatis cells. This work employed a novel synthetic oscillator 
construct developed by Wen-Han Yu to endogenously modulate KstR transcription; this 
oscillator has tunable pulse amplitude and frequency, based on the concentration of 
inducer chemicals (manuscript in preparation). We additionally analyzed cell growth, 
morphology, and cell division/lineage data for 800 M smegmatis cells to determine the 
relationship between cell growth and division timing. This work lends insight to a current 
debate about whether M smegma tis cell division is governed primarily by time-based or 
size-based control mechanisms [ 49, 51]. Our results are a compelling demonstration of 
the diverse types of information that can be obtained using quantitative single-cell 
measurements, specifically with respect to the cell biology of Mycobacteria. 
Section One: Quantifying KstR's Regulation of Predicted Target Genes 
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As described in Chapter 1, the Galagan group used ChiP-Seq based techniques to 
reconstruct the first genome-scale map of the M. tuberculosis gene regulatory network, 
identifying global binding sites for > 100 transcription factors [24] . This work resulted in 
thousands of predicted regulatory interactions and led to several key insights about links 
between biological pathways in Mycobactetia. However, ChiP-seq alone provides 
information only about associations between TFs and putative target genes, not about the 
nature of gene regulation (activation or repression) [89]. In effect, ChiP-seq mapping 
provides the topology/architecture of the regulatory network, but little information about 
the functional annotations of network edges. To gain further insight about the functional 
relationship between regulators and their gene targets - of critical importance for using 
the network map to make predictions about biology - requires integrating the topological 
data provided by ChiP-Seq with complementary systems identification techniques. The 
experiments described here are a demonstration of this type of integration, and our results 
enabled direct validation of gene regulatory interactions in single Mycobacteria cells. 
Subsection One: Tet-Inducible KstR 
The TF KstR has been shown to control a regulon that is involved in lipid 
metabolism pathways, especially cholesterol degradation, in M tuberculosis and in M 
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smegmatis [90]. KstR is part of the extended hypoxic response in MTB [91], and MTB is 
known to utilize host-derived fatty acids in vivo [92]. ChiP-Seq analysis revealed direct 
connections between the hypoxic response and lipid metabolism, mediated by the TFs 
Rv0081 and Rv0324 [24]. For these reasons, our group was interested in exploring the 
regulatory interactions of KstR in order to further elucidate its role in MTB pathogenesis. 
To perform these studies, we analyzed genetically engineered strains of M 
smegmatis using the microfluidics system described in Chapter 2. We first used strains of 
M smegmatis containing a Tet-inducible KstR-GFP fusion protein in a KstR mutant 
background; these strains additionally incorporated a construct containing the promoter 
for the gene MS603 8 fused to the gene for red fluorescent protein (RFP) in the episomal 
plasmid PmV261. These strains were designed and built by Suma Jaini. KstR was 
predicted via ChiP-Seq and overexpression microarray experiments to repress expression 
of the gene MS6038. Consistent with this prediction, induction ofKstR-GFP in single M 
smegmatis cells led to repression of the MS6038 promoter and a concomitant decrease in 
RFP expression. This experiment was repeated at varying A TC concentrations (1 0, 50, 
and 100 ug/mL) and with M smegmatis strains containing proteasome degradation tags 
of varying strength attached to the FP constructs as described in Chapter 2. A 
representative dataset from these experiments is shown in Figure 3.J, where the strain is 
KG-1/6038-2 and the ATC concentration is 50 ng/mL. Because the PMV261 plasmid is 
present at different copy numbers in different cells, direct cell-to-cell comparison is not 
possible in these data; however, the repressive effect ofKstR on 6038_RFP transcription 
was observed in >90% of the cells studied across all experiments. These experiments 
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served as proof of concept for the microfluidics platform itself, suggesting that it was 
indeed possible to observe gene regulation taking place within individual Mycobacteria 
cells in real time using this experimental setup. 
Figure 3.1. Movie montages showing expression ofTet-inducible KstR_GFP and 
MS6038p _ RFP after addition of ATC. As KstR is produced, expression of the KstR target 
MS6038 is repressed. 
Subsection Two: Oscillator-Driven KstR 
To further explore the relationship between KstR and the gene MS6038, we next 
used a construct containing a synthetic 'gene oscillator' architecture driving expression of 
KstR (designed and built by Wen-Han Yu; manuscript in preparation). In the gene 
oscillator construct, linked positive and negative feedback loops provide robust and 
tunable oscillations in the transcriptional activity of KstR. The motivation for using a 
gene oscillator was to gain the ability to provide endogenously-controlled periodic inputs 
to the system, thereby making it possible to observe frequency response characteristics of 
the system while being less sensitive to noise [93-95]. By modulating KstR concentration 
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at varying frequencies and measuring the dynamic responses of its regulated downstream 
elements, the frequency response characteristics of these elements can be measured. 
Though oscillatory gene expression systems had previously been built in E. coli [59, 96, 
97] and in mammalian cells [98], this work was the first such effort in Mycobacteria . 
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Figure 3.2. Schematic showing architecture of the synthetic oscillator circuit. 
The oscillator circuit (Figure 3.2) consists oflinked positive and negative 
feedback loops that utilize the repressor TetR, which represses transcription of the TetO 
promoter and is responsive to the chemical aTe as described in Chapter 2, and the 
activator NitR, which activates transcription of the nitA promoter and is responsive to the 
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chemical Caprolactam (Cap) [99]. A chimeric promoter region (Pnit/tet) was constructed 
that contains an activation operator site from the nitA promoter and two repression 
operator sites from the tetO promoter. The binding affinity of both NitR and TetR are 
modulated by the concentration of their inducer chemical (Cap and aTe, respectively), 
where Cap increases the binding affinity ofNitR for the nitA promoter and aTe decreases 
the affinity ofTetR to the tetO promoter (and therefore, addition of aTe de-represses 
TetO activity) [84]. This chimeric promoter therefore acts in a competitive manner 
whereby the activator NitR and the repressor TetR compete for binding to the promoter. 
Critically, the dimerization ofTetR necessary for its activity introduces an extra delay in 
the repressor component of the gene circuit, giving rise to the oscillatory behavior. 
Oscillatory behavior ofthis circuit was predicted computationally and verified in single-
cell measurements using the microfluidics system (Figures 3.3, 3.4). 
Tme (minutes) Time(h) 
Figure 3.3. Computational prediction of gene expression from the oscillator circuit, and 
experimentally obtained single-cell fluorescent traces from cells containing the circuit. 
Inducer concentrations: 25 ng/ml aTe, 14 mM Cap. 
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Figure 3.4. Representative image series of oscillatory KstR-RFP expression in single cells. 
At constant inducer concentration, single cells were found to exhibit sustained 
oscillations of KstR-RFP as predicted in the computational simulations. In total, 18 
aTe/Cap concentrations were studied. In each experiment, ~ 70 % of individual cells on 
average displayed robust oscillations over 24 hours of measurement with an average 
period of 4.5 hours (Figure 3.4). Cells that did not exhibit oscillations either exhibited 
monotonically decaying fluorescence, or undetectable fluorescence. Heterogeneous 
cellular responses in an isogenic cellular population have been widely observed and can 
be attributed to such cell-to-cell differences in cell size, age, cell cycle stage, and growth 
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rate; unequal partitioning of cellular components in dividing daughter cells; and extrinsic 
and intrinsic sources of noise in gene expression [38, 49, 100]. Variations in oscillatory 
period, timing and amplitude across the population can also be attributed to these factors. 
In addition, the plasmid used in these studies was based on the episomal pm V261 
background and plasmid copy number thus varied from cell to cell, which provides 
another source of cell-to-cell variation in the population. Previous work in E. coli reduced 
this variation by increasing the plasmid copy number to ~50 copies/cell, which resulted in 
robust oscillations in >99% of cells [59]. Raising the number of gene copies per cell was 
also shown decrease gene expression noise in Bacillus subtilis [ 101]. Further work could 
be done in Mycobacteria to increase plasmid copy number in this manner, or alternatively 
the oscillator circuit could be placed in an integrating plasmid (e.g. pMV306) to ensure 
that each cell contains exactly one copy of the circuit components, although this could 
still be subject to intrinsic noise due to "bursty'' mRNA production, especially since 
expression in this circuit is controlled via the balance of competing positive and negative 
regulatory elements [102]. 
After the functionality of the synthetic oscillator circuit was demonstrated using 
KstR-RFP, new strains of M smegmatis were constructed to explore the temporal 
dynamics of KstR regulatory interactions with two of its predicted target genes. For this 
purpose, two genes (MS1953 and MS6038) were selected; these were predicted by ChiP-
Seq to be directly regulated by KstR [24]. MS6038 is a predicted hydroxylase related to 
the MTB oxidoreductase gene Rv3570c, and MS1953 is a WhiB-like transcriptional 
regulator and is involved in cholesterol catabolism (annotations taken from tbdb.org). 
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The upstream promoter regions ofMS1953 and MS6038 were transcriptionally fused 
with a yellow fluorescence protein (YFP) gene as described in Chapter Two. All 
synthetic circuit components were built into the same plasmid backbone to maintain 
identical copy numbers of the components in individual cells. 
Using our microfluidics platform, we performed time-lapse fluorescent 
microscopy experiments on these strains (abbreviated here as KstR-1953 and KstR-6038) 
and obtained multi-color fluorescent images for >24 hours at single cell resolution. 
Representative single-cell traces of RFP and YFP fluorescence from one experiment 
(KstR-1953) are shown below in Figure 3.5. Each experiment resulted in single-cell data 
for ~50 cells, and over the course of all experiments we obtained 798 single-cell traces 
(376 single-cell traces for KstR-1953 and 422 single-cell traces for KstR-6038). These 
data traces contained information about both the "input" (i.e. KstR-RFP) and the "output" 
(the gene target, i.e. either MS6038-YFP or MS1953-YFP) and were processed and 
analyzed using the computational pipeline described in Chapter 2. 
Figure 3.5. Representative single-cell traces ofKstR-RFP and d(MS1953-YFP)/dt. 
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The responses ofboth MS-1953 and MS-6038 showed distinct dynamic behaviors 
corresponding to the KstR input. We measured this quantitatively by computing the cross 
correlation between KstR and its gene target; the cross-correlation is a measure of 
similarity of two waveforms as a function of a time-lag applied to one of them, and can 
therefore be used to visualize the relationship between the two fluorescence signals 
obtained in our single-cell data traces [72]. It was found that KstR-MSMEG1953 showed 
a positive correlation with a lag time of 1 hour, whereas KstR-MSMEG6038 displayed a 
negative correlation with a lag time of 1.25 hours (Figure 3.6). 
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Figure 3.6. Cross-correlations show regulatory activity of KstR on two of its targets. 
Interestingly, microarray data in a KstR knockout [90] had identified MS6038 as 
a strong repression target (MS6038 expression increased 136-fold in the KstR knockout) 
but did not indicate that MS1953 was a member of the KstR regulon, and KstR ChiP-Seq 
binding data for the two genes also suggested much stronger binding of KstR to 603 8 
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than to MS1953 (relative ChiP peak heights of92% and 1.3% respectively) [24]; and yet, 
comparison ofthe cross-correlation functions (1h vs. 1.25h) suggests that KstR directly 
regulates MSMEG 1953, instead of controlling it via some secondary regulatory pathway 
within the network. This result demonstrates that even relatively weak TF-target binding, 
as evidenced by low ChiP peaks, can indicate direct regulation. Additionally, KstR's role 
as an activator of 1953 is an important result because KstR has been shown to generally 
function as a repressor; this work thus shows bi-functional activity (activation and 
repression) for a single TF. In the case ofMS1953, its regulation by KstR is reasonable 
given MS1953's role in cholesterol catabolism and KstR's known role as a regulator of 
cholesterol metabolic pathways. Further exploration of the KstR regulon (and indeed the 
regulons of other key mycobacterial TFs) may yield additional surprising insights. 
Section Two: Morphology and Growth Measurements in Single Cells 
A major advantage of the microfluidic single-cell analysis platform is the wealth 
of data that can be obtained in a single experiment, not only in terms of throughput (i.e. 
measuring dozens of cells simultaneously) but in terms of the diverse types of data that 
are acquired. In particular, information about cellular morphology, growth, division, and 
lineage can be obtained at the same time as time-lapse fluorescence measurements. These 
measurements can used to better understand M smegmatis biology, separately from 
insights about gene regulation that are obtained. Thus, in the oscillator work described 
above, we obtained morphology, growth, division, and lineage data for 800 cells, and this 
data was analyzed via the MATLAB image processing pipeline. 
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In this analysis, our data was compared to recent reports of single-cell 
measurements in M smegmatis [ 49, 51 , 1 03]. In particular, two recent reports- one 
written by the McKinney group at the Swiss Federal Institute of Technology, Lausanne, 
and one from the Fortune group at Harvard School of Public Health- showed conflicting 
results with respect to the organization or 'rules' governing cell growth and division in 
Mycobacteria [49, 51]. Fortune et al. reported observations that suggested cell division 
in M smegma tis is regulated not by size-based control, as in E. coli, but rather by a time-
based control mechanism [ 49]. In other words, rather than cells needing to reach a certain 
minimum size before the cell division process began, M smegmatis cells in their 
experiments displayed time-based synchronized of division in single cells that was not 
correlated with cell size. In contrast to this report, McKinney et al. observed three things 
that suggested division in single M smegmatis cells was indeed related to cell size -
namely, that birth size and division time were negatively correlated, and that faster-
growing cells divided more quickly [51]. These trends more closely reflect the size-based 
control mechanisms of E. coli, because cells that are small at birth must grow more 
before they reach the requisite size for cell division [104]. 
With data from our microfluidics experiments, we were able to put our single-cell 
morphology and cell division measurements in the context of this current debate. It is 
important to note first that we observed canonical features of M smegmatis growth and 
division that agreed with those reported in the literature and our own flask-culture 
experiments [82]. Among these observations were a doubling time of 3-4 hours, 
asymmetric cell size between daughter cells after division events, and the classic "V"-
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shape of cells after division, as can be seen in Figure 3.7, which shows images of a 
growing M smegmatis microcolony in our microfluidic device, with individual cells 
segmented and numbered by MicrobeTracker. Additionally, because our analysis pipeline 
enables lineage tracking, we can directly measure differences in morphology, cell growth, 
and fluorescence between daughter cells (Figure 3.8). This figure shows the lineage 
stemming from one cell, "Cell 4," in a microcolony of M smegmatis cells and plots the 
cell size of each cell in the microcolony over time. Division events are clearly identifiable 
as a sudden decrease in cell size. 
Figure 3.7. Image series of single M. smegmatis cells showing cell segmentation and 
numbering, as well as the characteristic V-shape of newly divided cells. 
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Figure 3.8. Lineage trace diagram for a cell ("Cell4") in an M. smegmatis microcolony, and 
single-cell size measurements for the same microcolony. 
That our observations of basic single-cell growth and division characteristics 
agree with previously published reports was reassuring but not unexpected. If anything it 
served as an additional indicator that our platform did not impose additional stresses on 
single cells relative to flask culture. More surprising, though, was the degree of 
heterogeneity among single cells with respect to these measurements (cell size, growth 
rate, and division timing). For the 800 cells measured in this study, cell size at birth 
ranged from 1 micron to 4.5 microns, with a mean value of2.5 microns. Interdivision 
time ranged from 2-6 hours for the majority of cells, with a mean value of 4 hours, but we 
also observed slowly dividing cells with a division time of > 10 hours. This considerable 
heterogeneity between single cells agrees with the observations ofMcKinney and 
Fortune [ 49, 51], and as speculated by Fortune et al. , could be a factor underlying the 
differential susceptibility of single cells to antibiotic treatment. 
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After generating morphology, growth and division data for 800 cells, we explored 
correlations between cell size at birth, cell size at division, growth rate, and interdivision 
time in order to compare our results to those previously reported [ 49, 51]. Our 
observations are summarized in Figure 3.9. Strikingly, we found a positive correlation 
between cell size at birth and cell growth rate (a), and a negative correlation between cell 
size at birth and division time (b). Additionally, we observed that faster-growing cells 
divide more quickly than slowly-growing cells (c). These observations generally agree 
with those reported by McKinney et al., namely, that size-based control mechanisms of 
cell division seem to be in effect in M smegma tis [51]. We also observed that cell size at 
birth and cell size at division were positively correlated (d), which is not explained by 
strict size-control mechanisms of division timing. If division were solely a function of 
reaching a 'minimum' cell size, then all cells would divide after reaching that minimum 
cell size, regardless of what their size had been at birth. Further work is needed to address 
this question, but as discussed by McKinney et al. in [51], cell division could have a size-
based probability of occurrence after some minimum cell size is reached; because larger 
cells grow faster, this could lead to the positive correlation between cell size and birth 
and cell size at division that was observed in our data. While further work is needed to 
fully elucidate the mechanisms underlying size control and cell division in Mycobacteria, 
from this work and from the two cited reports it is clear M smegmatis grows and divides 
differently than better-studied model organisms such as E. coli. 
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Figure 3.9. Growth and division characteristics in M. smegmatis. Cell size at birth versus (a) 
growth rate and (b) doubling time. (c) Doubling time versus growth rate. (d) Cell size at 
birth versus at division. 
In summary, the work presented in this Chapter demonstrated that single-cell 
studies of M smegmatis, enabled by the microfluidics platform we developed, can be 
used to study diverse phenomena in single cells, and that the insights from single-cell 
experiments can lead to improved understanding of gene regulation, regulatory network 
structure and function, and processes of growth and division. Goals for future work using 
this methodology could include more comprehensively probing the KstR regulon, or to 
58 
provide direct validation ofTF regulatory network motifs (e.g. feed-forward loops) [33] 
that were predicted using ChiP-Seq and microarray data ~ Another extension of this work, 
analyzing single-cell responses to stress using morphological and time-lapse fluorescence 
data, is presented in Chapter 4. 
- - - --
59 
CHAPTER FOUR: Behavior of M. smegmatis in Response to Diverse Stresses 
This chapter reports observations from stress-response experiments performed 
using a microfluidic single-cell analysis platform. It will be organized into two sections, 
based on the type of stress to which the cells were exposed. The first section discusses 
cellular responses to antibiotic stress, namely D-Cycloserine (DCS). We found that 
individual cells exhibit considerable differences in their responses to D-Cycloserine-
induced stress, and that these differences have implications for cellular survival. The 
second section discusses hypoxia-induced stress responses in E. coli as well as in M 
smegmatis, and also described a modified microfluidic device that was constructed for 
these experiments that affords the ability to control oxygen tension in the on-chip 
microenvironment. 
Section One: HspX Expression and Cell Fate Under Antibiotic Stress 
In MTB, the heat-shock like protein HspX (also called Acr, alpha-crystallin), 
Rv2031c, is the most strongly-induced gene in the DosR regulon [105], and it is rapidly 
induced to ~80-fold expression at low oxygen tension (Figure 4.1, adapted from [26]). A 
2006 study found increased growth of an HspX deletion mutant in vivo and postulated 
that that hspX plays an active role in slowing the growth ofMTB during the transition to 
non-replicating persistence [106]. The precise function ofHspX is unknown, but it 
exhibits homology to chaperonin proteins that are involved in prevention of protein mis-
folding under stress conditions; important to note is that HspX is not induced by heat 
shock [107]. Based on these findings it is thought that HspX could function similarly to 
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other heat-shock proteins but in response to hypoxia and other host-mediated stresses as 
opposed to heat. Supporting this idea, HspX was found to be required for MTB growth in 
macrophages [ 1 08]. 
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Figure 4.1. Induction of HspX at low oxygen tension. Adapted from [26]. 
The strength of the regulatory link between DosR and HspX is such that HspX is 
commonly used as a surrogate indicator ofDosR regulon induction [109, 110]. In MTB, 
DosR is by far the strongest transcriptional regulator of HspX, though evidence also 
exists for binding of the HspX promoter by Rv0767c and Rv2745c, albeit with far weaker 
coverage (Figure 4.2, adapted from tbdb.org). Similarly, HspX was highly upregulated 
(6-fold) in an inducible DosR microarray experiment whereas similar experiments with 
inducible Rv0767c and Rv2745c resulted in -0.7 fold change ofHspX expression [24]. It 
is not known if the regulatory architecture upstream of HspX is identical in MTB and in 
M smegmatis, and additionally it is possible that as-yet uncharacterized TFs will strongly 
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bind to the HspX promoter. Further work (perhaps using techniques similar to those 
presented in Chapter Three) will be needed to precisely characterize the transcriptional 
regulators ofHspX in MTB and in M smegmatis and to arrive at a mechanistic 
understanding of the function of this protein. However, all studies cited above point to the 
utility of HspX as a reporter of DosR regulon induction. 
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Figure 4.2. Predicted transcriptional regulators of HspX. Taken from tbdb.org. 
To study stress responses of single M smegmatis cells, we constructed an M. 
smegmatis strain containing a promoter-FP construct for measurement ofHspX 
transcriptional activity. This construct was named JK306H and contains a copy of theM 
smegmatis HspX promoter fused to the sequence for an enhanced cyan fluorescent 
protein (ECFP) in the integrating plasmid pMV306 with a hygromycin resistance marker. 
Thus, CFP fluorescence is an indicator of transcriptional activity at the HspX promoter. 
We were interested in studying the response of M . smegmatis to diverse stresses, 
including hypoxia and other host-induced stresses as discussed in Section Two, as well as 
antibiotic stress. To this end, we treated a population oflog-phage M smegm.atis cells 
with the antibiotic D-cycloserine (DCS) and measured the effect of the drug on cell 
growth, HspX expression, and cell fate (via live-dead staining). DCS is a second-line 
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antituberculosis drug that inhibits cell wall biosynthesis via the inhibition of two enzymes 
[111]. These enzymes are alanine racemase (Air) and d-alanine d-alanine ligase (Ddl), 
which are involved in synthesizing peptidoglycans [112]; for instance, Alr converts L-
alanine to D-alanine, and it was found that Alr mutants of MTB required supplementation 
of growth medium with D-alanine for survival [113] and showed survival defects in vivo. 
The protocol for drug treatment experiments was as follows. Overnight culture 
(OD 0.4-0.6) of M smegmatis cells were loaded into a microfluidic device in antibiotic-
free 7H9 medium and allowed to grow in a monolayer at 37 degrees for one hour. After 
one hour in the device, fluorescence acquisitions at 1 OOX magnification were begun, with 
30 minutes between exposures. Simultaneously, brightfield images were acquired every 
15 minutes. For the data presented here, t=O is equivalent to the time at which fluorescent 
exposures were begun (i.e. the one hour 'acclimation' period is not included in the 
datasets). Cells grew in antibiotic-free medium for 3 hours, at which point the cells were 
exposed to 7H9 media containing DCS at the indicated concentration for several hours 
(1 0-100 ug/mL; the minimum inhibitory concentration of DCS forM smegma tis is ~40 
ug/mL). After drug treatment was sustained for 7-10 hours (as denoted for each 
experiment), DCS was removed and cells were allowed to recover in antibiotic-free 7H9 
medium. At the conclusion of these experiments, propidium iodide (PI) staining was 
performed. PI is a red fluorescent dye that permeates degraded cell membranes and thus 
serves as an indicator of cell death [114]. 
Surprisingly, we observed that addition ofDCS caused rapid and strong 
induction of HspX transcription in some M smegma tis cells, as observed by an increase 
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in ECFP fluorescence (Figure 4.3). Fluorescence was observed in high-intensity 'pulses ' 
of ECFP, denoting strong yet transient transcriptional activation of the HspX promoter. 
These fluorescence pulses occurred in a minority of the cells studied, approximately 30-
50% of all cells, and although the majority of pulsing cells exhibited exactly one pulse of 
fluorescence, 5-l 0% of pulsing cells exhibited > 1 fluorescence pulse. In the experiment 
depicted in Figure 4.3 below, 30 ug/mL DCS was introduced to the microfluidic device at 
time t=3 .5 hours after fluorescence acquisition began, and was removed at t=13.5 hours. 
Figure 4.4 shows image frames from this same experiment, with ECFP pulses in response 
to DCS addition visible in several cells. 
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Figure 4.3. Single-cell ECFP fluorescence traces in response to 30 ug/mL D-Cycloserine. 
M. smegmBti$ Expressing Hsp~ECFP in Responses to 30 ugtmL D-Cycl0$8rine 
Figure 4.4. Image frames showing single M. smegmatis cells expressing HspXp:ECFP in 
response to 30 ug/mL D-Cycloserine. 
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Figure 4.5, below, shows a similar drug treatment experiment in which cells were 
exposed to 100 ug/mL ofDCS for 13 hours. Of note in Figure 4.3 above and in Figure 
4.5 below is the fact that cells did not express ECFP fluorescence in the absence of drug; 
this is contrast to a previous report in which spontaneous pulses of the protein KatG were 
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observed in steady-state conditions [37]. While we refrain from assigning a mechanism 
underlying these pulses of transcriptional activity at the HspX promoter, it is likely that 
they are indicative of activation of some stress-response pathway within these cells. 
Slngl~ell HspXp-ECFP Intensity, DCS 100 uglml 
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Figure 4.5. Single-cell ECFP fluorescence traces in response to 100 ug/mL D-Cycloserine. 
Our MATLAB image-processing pipeline was expanded to include peak-finder 
functionality for processing of single-cell ECFP fluorescence traces. Representative 
single-cell fluorescence traces are shown in Figure 4.6 below, showing that several of 
these cells exhibited peaks of fluorescence intensity over the course of the time-lapse 
experiment. Cell lengths are plotted in these graphs as well so that division events can be 
seen. From these single-cell traces, population-wide statistics about ECFP pulses can be 
obtained and compared across experimental conditions. 
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Figure 4.6. Single-cell ECFP fluorescence traces in response to 30 ug/mL DCS. 
Single-cell cell length and growth rate measurements were also obtained for these 
experiments, and it was found that increased concentration of DCS resulted in a more 
rapid cessation of growth in the population (Figures 4. 7 -4.12). More cells grew while 
under drug treatment at 30 ug/mL than 100 ug/mL DCS as is apparent when comparing 
Figures 4.7 and 4.8. Resumption of growth after DCS removal occurred in fewer cells at 
an increased concentration ofDCS, apparent in Figures 4.9 and 4.10 showing average 
growth rate (micronslhr) in the population. 
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Figure 4.7. Single-cell length measurements under DCS treatment (30 ug/mL). 
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Figure 4.8. Single-cell length measurements under DCS treatment (100 ug/mL). 
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Figure 4.9. Single-cell growth rates, DCS 30 ug/mL. Green lines, single cells; black line, 
population average. 
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Figure 4.10. Single-cell growth rates, DCS 100 ug/mL. Green lines, single cells; black line, 
population average. 
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To explore the functional significance of pulsatile HspX expression in single 
cells, propidium iodide staining was performed at the conclusion of each experiment and 
live/dead statistics were quantified for all cells. Cells were grouped by number of 
fluorescence pulses, and the odds of survival (i.e. the probability of survival divided by 
the probability of death) were calculated as a function of the number of fluorescence 
pulses observed. At DCS concentrations ofboth 100 ug/mL and 30 ug/mL we found that 
cells that pulsed were more likely to die than cells that did not pulse (Figure 4.11 ), with 
p-values of0.16 and 0.09 respectively (one-tailed Fisher's exact test). Increased statistical 
power (i.e. higher numbers of cells) is needed to confirm this result; statistics were 
generated using 52 and 42 cells respectively. Figures 4.12 and 4.13 show that for a given 
drug treatment, pre- and post-drug growth rates are similar between persisters and non-
persistent cells. Finally, Figures 4.14 and 4.15 show that post-drug, but not pre-drug, 
growth rates are different between cells that pulse and cells that do not pulse. 
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Figure 4.11. Odds of cellular survival vs. number of HspXp-ECFP fluorescence peaks. 
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Figure 4.12. Single-cell growth rates pre- and post-addition of 30 ug/mL DCS. Red 
histograms, non-surviving cells. Green histograms, persister cells. 
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Figure 4.13. Single-cell growth rates pre- and post-addition of 100 ug/mL DCS. Red 
histograms, non-surviving cells. Green histograms, persister cells. 
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Figure 4.14. Growth rates pre-drug addition for pulsing vs. non-pulsing cells. 
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Figure 4.15. Growth rates post-drug addition for pulsing vs. non-pulsing cells. 
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Taken together, these results show several intriguing and interconnected 
observations about the behavior of M smegmatis cells under antibiotic stress. First is that 
M. smegmatis cells respond to DCS by slowing growth and by 'pulsing' transcription of 
the HspX promoter. Second is that higher DCS concentrations increase the proportion of 
cells that pulse, and hasten the response time of pulsing cells. Third, and perhaps most, 
interesting is that HspX pulsing is correlated with cell fate under DCS treatment. But 
what is the functional significance ofHspX pulsing, and why is it negatively correlated 
with cellular survival? As discussed above, DosR is the strongest transcriptional regulator 
ofHspX, and M smegmatis cells that are exposed to stresses such as hypoxia, NO, and 
CO exhibit a dormancy response that is analogous to that ofMTB [115]. However, in a 
study ofMTB persisters that screened for DCS-tolerant cells, DCS was not found to 
induce DosR transcription although the sensor kinase DosS was upregulated [ 5]. Though 
more work is needed to elucidate the mechanistic basis linking HspX pulsing to cellular 
survival under DCS treatment, several hypotheses shed light on this open question. HspX 
might be indicative of a stress response pathway that is initiated in the pulsing cells; these 
cells may be more highly sensitive to DCS due to some physiological parameter (e.g. cell 
age) or their internal state (e.g. a higher number of some cellular component linked to 
stress). HspX pulsing could either be indicative of an adaptive response, or could 
conceivably be in fact counterproductive or maladaptive (akin to a drowning person 
thrashing wildly). To resolve this question, DosR could be exogenously induced either 
using inducer chemicals (e.g. the nitric oxide donor S-nitrosoglutathione) [116] or by 
placing DosR under control of a constitutively-expressed promoter [ 117]. The purpose of 
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this would be to artificially induce HspXp-ECFP pulsing in high numbers of cells and to 
determine if this would result in increased or decreased susceptibility to DCS treatment. 
Another hypothesis stems from recent work showing 'altruistic' behavior in microbes, 
whereby some cells, at a fitness cost to themselves, produce molecular signals or other 
molecules that confer drug tolerance to other members of the population [ 118, 119]. This 
could be tested using the methods of inducing DosR described above, and co-culturing 
JK306H cells with wild-type M smegmatis cells to determine ifHspX-ECFP pulsing in 
JK306H cells led to increased survival of wild type M smegmatis. Future work will 
address these questions and build on the results presented here, as discussed in Chapter 5. 
Section Two: Cellular Responses to Hypoxia 
As described in Chapter 1, hypoxia has been identified as a key host-induced 
stress on MTB in vivo [8]. MTB initiates a well-characterized response to hypoxia, 
mediated in part by the transcription factor DosR, that involves coordinated 
transcriptional regulation of hundreds of genes and a host of metabolic changes [8-12]. 
The hypoxic induction of the DosR regulon is notable for its strength and speed, which 
suggest a critical functional role for the regulon in MTB's hypoxic adaptation. In vitro, 
hypoxia induces a state of non-replicating persistence (NRP) in MTB that closely 
resembles the state of the organism in human infection; critically, MTB in hypoxia-
induced dormancy exhibits increased tolerance to several classes of drugs [13-15]. 
Adaptations of MTB to hypoxia are therefore likely to play a major role in MTB 
pathogenesis, and may modulate drug sensitivity in vivo. 
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To explore the single-cell behavior of Mycobacteria in a hypoxic 
microenvironment, we built a "hypoxic chamber" on a microfluidic chip based on a 
recently reported device architecture [120] that incorporates large (50x200 micron) gas 
channels adjacent to the on-chip cell trap. These channels are perfused with nitrogen 
during the course of an experiment, which purges the on-chip microenvironment of 
oxygen due to the high gas permeability ofPDMS. To validate our ability to control 
oxygen tension on chip, we used two methods. First, we employed Ruthenium-coated 
glass cover slips, which fluoresces in the absence of oxygen [121, 122]; second, we built 
a hypoxia-inducible fluorescent strain of E. coli to monitor single-cell hypoxic induction 
in real-time [123]. Ruthenium fluorescence was measured in known environments of 
anoxic (0%) and ambient (20%) oxygen concentrations (Figure 4.16). The oxygen-
sensitive E. coli nar promoter was fused to ECFP and cultured in the microfluidic 
hypoxia device (Figure 4.17) to further validate our ability to control oxygen tension on-
chip while maintaining culture conditions amenable to live cells, and to monitor hypoxic 
response in single cells. The nar promoter is involved in anaerobic metabolism [31] and 
we saw uniform, strong induction ofnar:ECFP within 30 minutes of oxygen 
displacement in the microfluidic device, which is on the order of one E. coli cell doubling 
time (20 minutes). These preliminary studies lay the groundwork for future analogous 
studies in M smegmatis, specifically to address the question of whether hypoxic 
conditions confer a dmg-tolerant state in the organism and whether this state can be 
observed and quantified in single cells in real time. 
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Figure 4.16. Ruthenium fluorescence within a microfluidic 'hypoxia chamber.' 
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Ruthenium 
- Auorescence 
- Nitrogen (PSI) 
Figure 4.17. Induction of thenar promoter in E. coli in response to hypoxic conditions in a 
microfluidic device. Oxygen displacement began at time t=O. Time in minutes. 
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CHAPTER FIVE: Conclusions and Future Directions 
This chapter summarizes the results reported in this dissertation, and briefly 
outlines future directions for further studies of single Mycobacteria cells. The 
rnicrofluidic live-cell imaging platform we developed, in conjunction with our automated 
image processing pipeline, enabled us to study Mycobacteria species at the single-cell 
level, in order to investigate dynamic phenomena (e.g. gene regulation) as well as cell-to-
cell heterogeneity and its relationship to drug tolerance. These are related but disparate 
phenomena and we thus obtained diverse data about gene expression, drug tolerance, and 
cell growth and morphology under various conditions. Each of these datasets suggest 
directions for further study, which could lead to more comprehensive insights about 
processes such as the dormancy adaptation ofMTB. Additionally, all of the work 
presented here was perfmmed using M smegmatis, but future work in MTB itself or in 
the attenuated M bovis vaccine bacillus (BCG) would enable comparisons of any 
differences between these organisms, and would serve to enable more direct 
measurements ofMTB biology. These experiments are technically challenging to 
perform due to the need to have all equipment in biosafety level 3 facilities, as well as the 
24-hour doubling time of MTB and BCG as compared to 4 hours forM smegmatis. 
However, recent reports of single cell studies in MTB have emerged [50], and as the 
fields of microfluidics and single-cell systems biology mature these experiments will 
become more common. In general the future directions discussed below could be 
performed in M. smegmatis first as a proof of concept and then adapted to BCG or MTB, 
or if a microfluidic time-lapse imaging platform was installed in a BSL3 facility, this 
work could directly be performed in MTB itself. 
Section One: DosR Expression in Response to Hypoxia and Other Stresses 
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Our results with the E. coli nar promoter show that the microfluidic platform 
described in this work can be used to generate controlled hypoxic environments on-chip. 
This platform could be used to study DosR transcriptional activation and/or regulon 
induction in hypoxia using M. smegmatis or MTB. Remaining work needs to be done to 
more accurately calibrate the system for fine control, especially considering that MTB 
has been shown to enter two different stages of non-replicating persistence as the oxygen 
tension falls below 1% and 0.06% oxygen saturation respectively [124-126]. Microfluidic 
platforms offer for the first time the ability to study at the single-cell level the non-
replicating persistence of MTB in response to hypoxia. Because DosR is thought to act as 
a bistable switch due to its positive autoregulation, subpopulations of dormant and non-
dormant cells might co-exist in culture as oxygen tension decreases from ambient 
saturation down to <1 %; the fraction of cells entering dormancy may well be a function 
of oxygen tension, and this could be probed using the single-cell methods described here. 
For this work the DosR promoter and/or the DosR protein should be fused to a 
fluorescent protein so that transcriptional activation of DosR can be measured; most 
interesting would be if the HspX promoter were simultaneously monitored using a second 
color fluorescent protein construct, so that differences in DosR and HspX induction could 
be quantified in single cells. DosR expression is likely to be correlated with diminished 
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single-cell growth rates in hypoxic conditions, and this could also be shown directly 
using the single-cell platform. Additionally, the hypoxic response of DosR knockout 
strains of M. smegmatis and/or MTB could be analyzed at the single-cell level using this 
platform. Finally, drug tolerance of Mycobacterial cells could be investigated in the 
hypoxic microenvironment, which would serve as an in vitro model of host-like 
conditions. It would be interesting to determine whether induction of the DosR regulon is 
correlated with increased drug tolerance in these experiments, as it has been reported that 
DosR regulon induction per se is not a key mediator of drug tolerance in vivo [31]. 
Section Two: Further Investigation of the MTB Regulatory Network 
We showed direct evidence of gene regulation for two members of the KstR 
regulon, and used this both as validation of a synthetic oscillator construct and as proof of 
concept ofthis technique in Mycobacteria. To more comprehensively understand the 
function of KstR or indeed any regulator in the MTB regulatory network, these studies 
should be extended to include more members of the TF's regulon. Additionally, this 
single-cell analysis platform could be used to directly validate feed-forward loops and 
other network motifs that have been predicted computationally; these would require two-
or three-color fluorescence measurements simultaneously but would potentially lend very 
powerful insights to ongoing efforts at regulatory network reconstruction [24]. Similarly, 
some of the putative links between TFs determined by ChiP-seq could be directly probed 
using multi-color fluorescence constructs and inducible promoter systems. The results 
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presented here focused on TF-gene target measurements, but providing direct evidence of 
regulation at the level ofTFs would be more directly applicable in answering some of the 
questions that have arisen from current network reconstruction efforts. These include 
linking the regulators DosR, Rv0081, KstR, and Rv3024, which were predicted in [24] to 
form a core subnetwork linking the hypoxic response adaptation with cholesterol and 
lipid metabolism pathways. Finally, as described in Section One of this chapter, an 
interesting extension of this work would be to perform these gene regulation studies in 
MTB itself or in M bovis BCG, either recapitulating the work we presented in M 
smegmatis or investigating other TFs and pathways. This work could also incorporate the 
addition of specific metabolites to the on-chip environment, e.g. using cholesterol to de-
repress KstR transcription, thus using the metabolites themselves as 'inducers' and 
observing specific TF or gene induction in response. 
Section Three: Studying Mycobacterial Infection of Macro phages on-Chip 
Finally, the microfluidic platform described here could be incorporated with 
macrophage culture on-chip and used for the long-term imaging of MTB infection 
processes. Several groups have used microfluidic devices to obtain measurements from 
living macrophages, demonstrating the technical feasibility of on-chip macrophage 
culture [127, 128]. Fluidically isolated seeding chambers were used to perform control 
and experimental assays in parallel, and on-chip valves were used to sequentially perform 
cell stimulation, permeabilization and analysis steps. Critically, macrophages in the 
microfluidic device did not express environmental-stress proteins in response to shear 
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rates produced by fluid flow. Fluorescent tags could be used to monitor gene expression 
changes in the macrophages themselves, as well as the mycobacterial cells, in response to 
infection [ 129]. This technique would represented one step closer towards true in vivo 
single-cell biology and could be used for many different single-cell analyses, e.g. to test 
drug responses in single cells in the macrophage environment or to examine DosR 
transcriptional induction in single cells at different physical locations within the 
macrophage. It is also possible that gene expression and/or morphological characteristics 
of mycobacterial cells would be largely similar for all cells within the same macrophage, 
but different for cells residing in different macrophages; this would suggest variability 
within the macrophage environment. With these experiments as with the other future 
directions outlined in this Chapter, the power of these techniques would be to observe 
interesting correlations between single-cell phenotypes and behavior, e.g. DosR induction 
and antibiotic tolerance, as this type of investigation truly requires single-cell analysis 
and has thus been unexplored until today. The broader aim of this work is to better 
elucidate our understanding of MTB biology, specifically with regard to pathogenesis and 
infection, in the hope that this understanding will lead to the development of new tools 
for combating this ubiquitous and devastating human pathogen. Systems biology at the 
single-cell level is truly a fertile ground for future research, and it will be exciting to see 
what new insights come of these techniques. 
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APPENDIX 1: SAMPLE MATLAB CODE 
This function, drawGrowthRate.m, draws single-cell growth rates, taking as input the cell 
array structures CellFluore and ExptData which contain the cell meshes drawn by the 
MicrobeTracker program as well as all experimental parameters. 
function [)•DravGrovthRate2(vararg1n) 
e~ptD~t~ = ev~l~n( "b~s • , •exptDu t u' )l 
C~llFluorc: ~val~n( 'bc ~ r.' r ' Cr.l1Fluor.r. 1 ): 
T = e xptoata.l'; 
f !.gure( 1 t~ ll:'i1r.' ~ '<:ra.,..th l " i Uu:nbr.r i t: 1 n 1 , • nn 1 , ' 1-= o !'O !. t. i.o n 1 , ( 1, l, 1920, 1080 I , ~ Un ! t!; 1 , • p.:.xr.l !i' ) : 
n~berOfL~nes = s~2e(Cel1Fluore.Filterlength,2); 
dupT~~~n9 = Cellfluore.duplicateTiming; 
% Xake ttae colors 
f~nalColors = 2eros(numberOfLines,3); 
for ~ = l:nu~berOfL:ne& 
f~n., lColnrs(i,!) = (rand, (0.4)•rand + 0.2, ~:and); 
<!nd 
f~nalColors = finalcolors•0.97; 
%Get the r!gh~ callB 
GoodCells = Cellfluore.CellNum; 
\C.c l';. cr.ll lr.ngt.h and d ( l~ngT. h) /cit i nform~t:.inn 
~p•CellFluore.f!lterlength; 
t~~D~ff = d~ff(t~p); 
t~~D~ff = T(2:s~zn(Cn11Fluor~.Filtnrlnnqth,l)); 
t !)on' sho·.r doubl~ ng events i n he gro,•th plo 
for ~ - l:lr.nqth(CoodCnl ls ) 
end 
for t~po!nt • l:lengtb(timeDiff) 
H (dupT~::~~:.ng(t~::r.epo~nt,~) = 1) 
~(t:~~point,il = NaN; 
end 
<!ltd 
bold ott 
for • - l:length(GoodCellsJ 
end 
i f GoodCell9( ! ) • • 0 
l:.ne(T,t~p(:,(:)), 'Color • ,t:.nalColors(:.,:), 'L:ne~:.dth' ,O.S, 'L:nestyle' , '-' ); 
end 
~.:.nxax = yli.lll; 
:n;;nMi1x(2J = rninXi1><(2J•0.995; 
yl;~((~" nXax( l ) ~~nMax(~)lll 
%Drug Info 
if -~se~pty(exptDi1ti1.onTime) 
d~ugT~~~rray = (nxptOata.onTimr-, nxptOata.offTimc); 
drugAbbrev e ( strtok(exptDAtA.drugName, ' ' ), ' ' ); 
drugAdded = [drugAbbrev, 'added' ); drugRe::r.oved = (drugAbbrev, 're:r.oved' ); 
vl~ne(druqT~~~rri1y,{ •k - . · , ·k - . ' },{drug~dded, druqRe~~ved}J; 
c;tnd 
'HlYJXl ":. a In!c 
i f -.::se~pty(e~ptDi1ti1.hypo~Dnl 
hypqxT~~A~ray = (nxptData.hypoxOn, cxptOata.hypoxOff); 
~·1!ne(hypoxT!:r.eArray, { ' k . ' , 'k . ' }, { ' llyp.o>:!i1' , ' ' }); 
end 
% Construc t Title 
titleText =[ 'Cel l Length , ' , ' ' , • •• 
exptData.drugName, ' ug/mL' ): 
title(titl eText, 'FontSize ', 16, 'interpreter' , 'latex' ): 
xlabel( 'Hours' , 'Font Size' ,l6, 'interpreter' , 'latex' ): 
ylabel( 'Cel l Length (microns)' , 'FontSize' ,l6, 'interpreter' , 'latex' ): 
qoodindices = []: 
for i = l:length(GoodCells) 
if GoodCells(i) -= 0 
goodindices = horzcat(goodindices,i): 
end 
end 
% This takes tmpDiff from only the cells we care about 
tmpDiff = tmpDiff(:,goodindices): 
averagetmpDiff = mean(tmpDiff,2): 
%Disre gard final frame 
for i = length(averaqetmpDiff)-l:length(averaqetmpDiff) 
averagetmpDiff(i)=O: 
end 
% This filte r s drastic c hanges in tmpDiff 
for i= l:lenqth(tmpDiff(:,l)) 
end 
for j = l:length(tmpDiff(l,:)) 
end 
if (tmpDiff(i,j))<-0.2 
tmpDiff(i,j) • O: 
e l seif (tmpDiff(i,j))>l 
tmpDiff(i,j)=l: 
end 
% This smooths averageTmpDiff with a moving avg window o f 3 
windowsize 3: 
filterData = filter(ones(l,windowSize)/windoWSize,l,averaqetmpDiff); 
% This finds the average growth rate 
filterSingleCellTraces = zeros(size(tmpDiff)): 
for i= l:length(tmpDiff(l,:)) 
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filterSingleCellTraces(:,i) = filter(ones(l,windowSize)/windoWSize,1,tmpDiff(:,i)): 
n - length(filterSinqleCellTraces(:,i)): 
f = fft(filterSingleCellTraces(:,i)): 
f(n/2+1-S:n/2+5) = zeros(lO,l); 
filterSinqleCellTraces(:,i) = real(ifft(f)); 
end 
averageSingleCell = mean(filterSinqleCellTraces,2): 
% Draw avg gr owth r ate 
figure 
hold on 
beta- length(T); 
framesPerHour = 4; 
% Green curves 
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for i = 1alength(goodindices) 
plot(T(2:beta),framesPerHour*filterSingleCellTraces(:,i),' LineWidth' ,1, 'Color• ,[0.5~ 
0.95 0.7)); 
end 
numCellsPlotted c strcat(num2str(length(goodindices)), ' Cel l s Plotted' ); 
% Black curve 
plot(T(2alength(T)),framesPeraour*averageSingleCell, 'Linewidth' ,4, 'Color' ,[0.1 0.1~ 
0.2 ) , 'LineStyle' , '-' ); 
ylim([ - 0.1 2)); 
%Drug Info 
if -isempty(exptData.onTime) 
drugTimeArray • (exptData.onTime, exptData.offTime); 
drugAbbrev a [ strtok(exptData.drugName, ' ' ), ' '); 
drugAdded = [drugAbbrev, 'added '); drugRemoved = [drugAbbrev, •removed' ); 
vline(drugTimeArray,{' k- .' , 'k-. '},{drugAdded, drugRemoved}); 
end 
%Hypoxia Info 
if -isempty(exptData.hypoxOn) 
hypoxTimeArray a (exptData.hypoxOn, exptData.hypoxOff); 
vline(hypoxTimeArray,{' k-.' , 'k- . ' },{ 'Hypoxia' , ' ' }); 
end 
% Construct Title 
titleText a [ 'Cell Growth Rate (microns/hr),' , ' • , • •• 
exptData.drugName, ' ug/mL' ); 
title(titleText, ' FontSize• , 16, 'interpreter' ,' latex' ); 
xlabel( 'Hours' , 'FontSize' ,16, 'interpret er' , ' l atex' ); 
ylabel( 'Cell Growth Rate, um/hr ', 'FontSize' ,l6,' interpreter' , ' l atex '); 
hline(O, •r- . ' ); 
text(max(xlim)*0.25,max(ylim)*0.95, numCellsPlotted, 'FontSize •, 15); 
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